# Dermala

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dermala

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.dermala.com
- Total disclosed funding: $7.7M
- Latest round: Series A (Nov 9, 2020)
- Investors on record: 4

## About

Dermala Inc. is a skincare company focused on personalized acne treatment solutions utilizing a proprietary SE Microbiome Complex®, offering a range of supplements and topical products aimed at promoting skin health.Founded in 2014 in San Diego, US, Dermala Inc. specializes in acne treatment solutions. The company has conducted 3 funding rounds, with its most recent being a Series A round on November 9, 2020, where it raised USD 6.73 mn. This round was co-led by Johnson & Johnson Innovation and True Wealth Ventures, with additional participation from Seventure and The Cove Fund. Lada Rasochova serves as both the CEO and founder of the company.Dermala specializes in personalized acne treatment solutions that leverage a unique SE Microbiome Complex®. The company’s product lineup includes a range of supplements and topical treatments aimed at addressing acne from both internal and external perspectives. Core offerings include the Pre + Probiotic + Vitamin Acne Supplement, DIM Acne Supplement, and various topical products such as Probiotic Acne Treatment Pads, Probiotic Acne Facial Moisturizer, and Gentle Probiotic Acne Cleanser. These products are designed to target the root causes of acne, promote skin health, and enhance the skin's microbiome. Dermala primarily serves consumers in the United States, providing tailored solutions for individuals experiencing acne-related challenges, with a focus on personalizing treatment based on individual skin types and conditions.Dermala generates revenue through direct-to-consumer sales of its skincare products, which are available for purchase via their online platform. The company employs a transactional structure that targets individual customers, offering a variety of products with distinct pricing plans. For example, the Pre + Probiotic + Vitamin Acne Supplement is priced at USD 36, while the DIM Acne Supplement is listed at USD 26. This pricing strategy reflects the company's commitment to providing accessible and effective skincare solutions. Additionally, Dermala offers incentives such as discounts for first-time buyers, further enhancing customer engagement and driving sales.In November 2020, Dermala Inc. raised USD 6.73 mn in Series A funding, primarily to expand its research and development activities and scale its operations, manufacturing, and commercial efforts for its acne products. The company plans to introduce new products, aiming to enhance its portfolio further. Expansion into new geographic markets is also on the agenda, with targeted timelines for specific regions to be announced in the near future.

## Funding rounds

- Series A, Nov 9, 2020, $6.7M — Seventure Partners, Johnson & Johnson Innovation, True Wealth Ventures, Cove Fund
- Seed, Apr 16, 2018, $1M — True Wealth Ventures

## Investors

- True Wealth Ventures (https://capitalatlas.ai/funds/true-wealth-ventures) — Seed, Series A
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series A
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- Cove Fund (https://capitalatlas.ai/funds/cove-fund) — Series A